MED Medifast Inc

  1. Stocks
  2. Consumer Cyclical
  3. NYSE: MED

Price (delayed)

$252.99

Market cap

$2.98B

P/E Ratio

28.95

Dividend/share

$4.52

EPS

$8.74

Enterprise value

$2.83B

Sector: Consumer Cyclical
Industry: Personal Services
Website: https://www.medifast1.com

Highlights

The equity has grown by 50% YoY and by 12% from the previous quarter
The EPS has increased by 32% year-on-year and by 8% since the previous quarter
The price to earnings (P/E) is 56% more than the last 4 quarters average of 18.5 and 12% more than the 5-year quarterly average of 25.8

Key stats

What are the main financial stats of MED
Market
Shares outstanding
11.77M
Market cap
$2.98B
Enterprise value
$2.83B
Valuations
Price to earnings (P/E)
28.95
Price to book (P/B)
18.94
Price to sales (P/S)
3.19
EV/EBIT
21.05
EV/EBITDA
19.97
EV/Sales
3.02
Earnings
Revenue
$934.84M
EBIT
$134.27M
EBITDA
$141.54M
Free cash flow
$139.31M
Per share
EPS
$8.74
Free cash flow per share
$11.83
Book value per share
$13.36
Revenue per share
$79.42
TBVPS
$23.45
Balance sheet
Total assets
$276.08M
Total liabilities
$118.84M
Debt
$11.16M
Equity
$157.25M
Working capital
$122.96M
Liquidity
Debt to equity
0.07
Current ratio
2.1
Quick ratio
1.57
Net debt/EBITDA
-1.08
Margins
EBITDA margin
15.1%
Gross margin
74.6%
Net margin
11%
Operating margin
14.4%
Efficiency
Return on assets
42.4%
Return on equity
78.4%
Return on invested capital
817.2%
Return on capital employed
81.5%
Return on sales
14.4%
Dividend
Dividend yield
1.79%
DPS
$4.52
Payout ratio
56%

MED stock price

How has the Medifast stock price performed over time
Intraday
-0.69%
1 week
-5.68%
1 month
4.1%
1 year
167.77%
YTD
28.85%
QTD
28.85%

Financial performance

How have Medifast's revenue and profit performed over time
Revenue
$934.84M
Gross profit
$697.82M
Operating income
$134.16M
Net income
$102.86M
Gross margin
74.6%
Net margin
11%
The operating income rose by 47% YoY and by 17% QoQ
MED's net income is up by 32% YoY and by 9% QoQ
MED's revenue is up by 31% year-on-year and by 11% since the previous quarter
Medifast's gross profit has increased by 30% YoY and by 11% from the previous quarter

Growth

What is Medifast's growth rate over time

Valuation

What is Medifast stock price valuation
P/E
28.95
P/B
18.94
P/S
3.19
EV/EBIT
21.05
EV/EBITDA
19.97
EV/Sales
3.02
The price to earnings (P/E) is 56% more than the last 4 quarters average of 18.5 and 12% more than the 5-year quarterly average of 25.8
The EPS has increased by 32% year-on-year and by 8% since the previous quarter
MED's P/B is 84% above its 5-year quarterly average of 10.3 and 54% above its last 4 quarters average of 12.3
The equity has grown by 50% YoY and by 12% from the previous quarter
The P/S is 60% higher than the last 4 quarters average of 2.0 and 28% higher than the 5-year quarterly average of 2.5
MED's revenue is up by 31% year-on-year and by 11% since the previous quarter

Efficiency

How efficient is Medifast business performance
The return on invested capital has surged by 87% since the previous quarter
MED's ROE is up by 17% YoY but it is down by 2.2% QoQ
The return on sales has increased by 12% year-on-year and by 5% since the previous quarter
The ROA has increased by 11% YoY

Dividends

What is MED's dividend history
DPS
$4.52
Dividend yield
1.79%
Payout ratio
56%
Recent dividends

Financial health

How did Medifast financials performed over time
The total assets is 132% greater than the total liabilities
The total assets is up by 42% year-on-year and by 6% since the previous quarter
The company's quick ratio rose by 32% YoY and by 3.3% QoQ
Medifast's debt is 93% less than its equity
The equity has grown by 50% YoY and by 12% from the previous quarter
Medifast's debt to equity has decreased by 46% YoY and by 22% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.